PortfoliosLab logoPortfoliosLab logo
CLDX vs. ESOA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLDX vs. ESOA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Celldex Therapeutics, Inc. (CLDX) and Energy Services Of America Corp (ESOA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLDX achieves a 40.13% return, which is significantly lower than ESOA's 76.78% return. Over the past 10 years, CLDX has underperformed ESOA with an annualized return of -5.67%, while ESOA has yielded a comparatively higher 26.79% annualized return.


CLDX

1D
-1.10%
1M
-0.81%
6M
54.72%
YTD
40.13%
1Y
71.52%
3Y*
3.07%
5Y*
-2.75%
10Y*
-5.67%
ALL TIME*
-5.66%

ESOA

1D
1.27%
1M
-19.48%
6M
60.30%
YTD
76.78%
1Y
42.00%
3Y*
73.16%
5Y*
49.28%
10Y*
26.79%
ALL TIME*
23.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$36.64M$35.57M$33.98M
$2.60M$2.19M$2.55M

CLDX vs. ESOA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CLDX
Celldex Therapeutics, Inc.
40.13%7.48%-36.28%-11.02%15.35%120.55%685.65%-24.88%-93.03%-19.77%
ESOA
Energy Services Of America Corp
76.78%-34.42%111.44%140.93%-22.02%223.53%32.47%-30.56%38.82%-36.06%

Correlation

The correlation between CLDX and ESOA is 0.11, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.11

Correlation (3Y)
Balances recent behavior with more history.

0.11

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.10

Correlation (10Y)
Provides a long-term view across more market conditions.

0.08

Correlation (All Time)
Calculated using the full available price history since Nov 16, 2012

0.05

Fundamentals

Market Cap

CLDX:

$2.53B

ESOA:

$268.33M

EPS

CLDX:

-$4.27

ESOA:

$0.54

PS Ratio

CLDX:

3.09K

ESOA:

0.55

PB Ratio

CLDX:

5.55

ESOA:

3.10

Total Revenue (TTM)

CLDX:

$820.00K

ESOA:

$440.96M

Gross Profit (TTM)

CLDX:

$805.00K

ESOA:

$52.66M

EBITDA (TTM)

CLDX:

-$216.32M

ESOA:

$27.20M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLDX vs. ESOA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CLDX
CLDX Risk / Return Rank: 8383
Overall Rank
CLDX Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
CLDX Sortino Ratio Rank: 8282
Sortino Ratio Rank
CLDX Omega Ratio Rank: 7979
Omega Ratio Rank
CLDX Calmar Ratio Rank: 8787
Calmar Ratio Rank
CLDX Martin Ratio Rank: 8787
Martin Ratio Rank

ESOA
ESOA Risk / Return Rank: 6565
Overall Rank
ESOA Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
ESOA Sortino Ratio Rank: 6666
Sortino Ratio Rank
ESOA Omega Ratio Rank: 6363
Omega Ratio Rank
ESOA Calmar Ratio Rank: 6767
Calmar Ratio Rank
ESOA Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CLDX vs. ESOA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Celldex Therapeutics, Inc. (CLDX) and Energy Services Of America Corp (ESOA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CLDXESOADifference
Sharpe ratioReturn per unit of total volatility

+0.78

Sortino ratioReturn per unit of downside risk

+0.87

Omega ratioGain probability vs. loss probability

1.26

1.15

+0.10

Calmar ratioReturn relative to maximum drawdown

3.04

1.07

+1.97

Martin ratioReturn relative to average drawdown

7.81

2.25

+5.56

CLDX vs. ESOA - Sharpe Ratio Comparison

The current CLDX Sharpe Ratio is 1.31, which is higher than the ESOA Sharpe Ratio of 0.53. The chart below compares the historical Sharpe Ratios of CLDX and ESOA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CLDX vs. ESOA - Drawdown Comparison

The maximum CLDX drawdown since its inception was -99.73%, which is greater than ESOA's maximum drawdown of -76.67%. Use the drawdown chart below to compare losses from any high point for CLDX and ESOA.


Loading charts...

Drawdown Indicators


CLDXESOADifference

Max Drawdown

Largest peak-to-trough decline

-99.73%

-76.67%

-23.06%

Max Drawdown (1Y)

Largest decline over 1 year

-24.23%

-31.16%

+6.93%

Max Drawdown (3Y)

Largest decline over 3 years

-70.84%

-57.43%

-13.41%

Max Drawdown (5Y)

Largest decline over 5 years

-73.11%

-57.43%

-15.68%

Max Drawdown (10Y)

Largest decline over 10 years

-97.90%

-69.62%

-28.28%

Current Drawdown

Current decline from peak

-93.29%

-25.65%

-67.64%

Average Drawdown

Average peak-to-trough decline

-78.14%

-32.83%

-45.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.40%

15.07%

-5.67%

Volatility

CLDX vs. ESOA - Volatility Comparison

Celldex Therapeutics, Inc. (CLDX) and Energy Services Of America Corp (ESOA) have volatilities of 13.11% and 13.37%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLDXESOADifference

Volatility (1M)

Calculated over the trailing 1-month period

13.11%

13.37%

-0.26%

Volatility (6M)

Calculated over the trailing 6-month period

37.30%

49.65%

-12.35%

Volatility (1Y)

Calculated over the trailing 1-year period

56.28%

62.68%

-6.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

57.29%

75.82%

-18.53%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.91%

95.97%

-18.06%

Dividends

CLDX vs. ESOA - Dividend Comparison

CLDX has not paid dividends to shareholders, while ESOA's dividend yield for the trailing twelve months is around 0.90%.


PositionTTM202520242023202220212020201920182017
CLDX
Celldex Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ESOA
Energy Services Of America Corp
0.90%1.47%0.24%1.84%0.00%0.00%0.00%6.49%0.00%5.88%

Financials

CLDX vs. ESOA - Financials Comparison

This section allows you to compare key financial metrics between Celldex Therapeutics, Inc. and Energy Services Of America Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


CLDX and ESOA have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ESOA has higher volatility (13.37%) compared to CLDX (13.11%). In terms of maximum drawdown, CLDX dropped -99.73% vs ESOA's -76.67%.

CLDX currently has the higher Sharpe Ratio (1.31 vs 0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLDX and ESOA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer